STEPHANIE MCQUARTERS: Open Payments
NPI 1598284358 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 18 payments from 6 companies in 2025. Trend: 2023 $1,885 · 2024 $469 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $219 |
| Vanda Pharmaceuticals Inc. | 2 | $150 |
| Janssen Pharmaceuticals, Inc | 10 | $136 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $16 |
Products named: FANAPT, AUSTEDO XR, UZEDY, INVEGA SUSTENNA, SPRAVATO, COBENFY, ABILIFY MAINTENA, VRAYLAR.
Industry payments across OK — which companies pay providers there.
